Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2024

Jul 9, 2024

32093_dirs_2024-07-09_286ca4b7-ae95-46ba-bea1-ecca6581758c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2024-07-03

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-07-03 Common Stock X 5187824 Acquired 42172003 Direct
2024-07-03 Common Stock X 69020 Acquired 561089 Indirect
2024-07-03 Common Stock X 49312 Acquired 400877 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-07-03 Warrant (right to buy) $11 P 2593912 Acquired 2029-07-03 Common Stock (2593912) Direct
2024-07-03 Warrant (right to buy) $11 P 2593912 Acquired 2029-07-03 Common Stock (2593912) Direct
2024-07-03 Warrant (right to buy) $11 P 34510 Acquired 2029-07-03 Common Stock (34510) Indirect
2024-07-03 Warrant (right to buy) $11 P 34510 Acquired 2029-07-03 Common Stock (34510) Indirect
2024-07-03 Warrant (right to buy) $11 P 24656 Acquired 2029-07-03 Common Stock (24656) Indirect
2024-07-03 Warrant (right to buy) $11 P 24656 Acquired 2029-07-03 Common Stock (24656) Indirect

Footnotes

F1: The Reporting Person acquired the shares of common stock and the warrants pursuant to the exercise of subscription rights in connection with the Issuer's previously announced rights offering (the "Rights Offering"), as disclosed in the Registration Statement on Form S-3, as amended, and certain Current Reports on Form 8-K filed by the Issuer with the SEC.

F2: Pursuant to the terms of the Rights Offering, the Reporting Person purchased units at a price of $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock at an exercise price of $11.00 per whole share. The warrants differ only in their redemption provisions.

F3: Shares and warrants are held by Genius 24C Inc., of which the Reporting Person is the sole shareholder.

F4: Shares and warrants are held by Blazon Corporation, of which the Reporting Person is the sole shareholder.